Skip to main content

Peer Review reports

From: Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone

Original Submission
7 May 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 May 2023 Reviewed Reviewer Report
5 Aug 2023 Reviewed Reviewer Report - Ludmila Zubarovskaya
25 Aug 2023 Reviewed Reviewer Report - Begül Yağcı-Küpeli
11 Sep 2023 Author responded Author comments - Rui Zhang
Resubmission - Version 3
11 Sep 2023 Submitted Manuscript version 3
10 Oct 2023 Reviewed Reviewer Report - Ludmila Zubarovskaya
5 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
5 Dec 2023 Editorially accepted
3 Jan 2024 Article published 10.1186/s12887-023-04465-5

You can find further information about peer review here.

Back to article page